Document Detail

Influence of salt intake on the antihypertensive effect of carvedilol.
MedLine Citation:
PMID:  8104238     Owner:  NLM     Status:  MEDLINE    
AIM: To investigate whether moderate sodium restriction can increase the proven antihypertensive effect of carvedilol, a newly developed beta-blocker with vasodilating properties.
METHOD: A randomly allocated double-blind crossover in 19 patients.
RESULTS: Lowering dietary salt increased the fall in blood pressure obtained with carvedilol.
L M Ruilope; V Lahera
Related Documents :
7473538 - Salt and blood pressure revisited.
7863648 - Effect of supplemental dietary calcium on the development of doca-salt hypertension in ...
9649558 - Dietary supplement with vitamin c prevents nitrate tolerance.
18049018 - Report of the working group for dietary salt reduction of the japanese society of hyper...
15960408 - The proseal laryngeal mask airway size selection in male and female patients in an asia...
9862588 - A comparison of demand-valve and bag-valve ventilations in a swine pneumothorax model.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of hypertension. Supplement : official journal of the International Society of Hypertension     Volume:  11     ISSN:  0952-1178     ISO Abbreviation:  J Hypertens Suppl     Publication Date:  1993 Jun 
Date Detail:
Created Date:  1993-10-21     Completed Date:  1993-10-21     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  8501422     Medline TA:  J Hypertens Suppl     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  S17-9     Citation Subset:  IM    
Hypertension Unit, 12 de Octubre Hospital, Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / pharmacology,  therapeutic use*
Antihypertensive Agents / pharmacology,  therapeutic use*
Blood Pressure / drug effects
Carbazoles / pharmacology,  therapeutic use*
Diet, Sodium-Restricted*
Double-Blind Method
Hypertension / drug therapy*,  physiopathology
Propanolamines / pharmacology,  therapeutic use*
Vasodilator Agents / pharmacology,  therapeutic use*
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Antihypertensive Agents; 0/Carbazoles; 0/Propanolamines; 0/Vasodilator Agents; 0K47UL67F2/carvedilol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A chemical screening strategy for the dereplication and prioritization of HIV-inhibitory aqueous nat...
Next Document:  Antihypertensive treatment with a dual-acting beta-blocker in the elderly.